Clinical trials
Phase 3 Severe Acute Respiratory Syndrome trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Respiratory Diseases, Mexico | 2 |
| AstraZeneca | 1 |
| Novavax | 1 |
| Rigel Pharmaceuticals | 1 |
| Veru Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Severe Acute Respiratory Syndrome | 6 |
| COVID-19 | 5 |
| Coronavirus Infections | 2 |
| Infections | 1 |
| Influenza, Human | 1 |
| Lung Diseases | 1 |
| Pneumonia | 1 |
| Pneumonia, Viral | 1 |
| Respiratory Distress Syndrome | 1 |
| Respiratory Tract Infections | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.